Heinz‐peter Schultheiss

Heinz‐peter Schultheiss's AcademicInfluence.com Rankings

Medical

#1827

World Rank

#2204

Historical Rank

Cardiology

#148

World Rank

#151

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Heinz‐peter Schultheiss Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Heinz‐peter Schultheiss's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. (2013) (2213)
Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. (2015) (1708)
Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas (2003) (1635)
The Cardiac Mechanical Stretch Sensor Machinery Involves a Z Disc Complex that Is Defective in a Subset of Human Dilated Cardiomyopathy (2002) (795)
High Prevalence of Viral Genomes and Multiple Viral Infections in the Myocardium of Adults With “Idiopathic” Left Ventricular Dysfunction (2005) (663)
Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults. (2003) (632)
Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases. (2020) (568)
Viral Persistence in the Myocardium Is Associated With Progressive Cardiac Dysfunction (2005) (550)
Utility of Doppler Echocardiography and Tissue Doppler Imaging in the Estimation of Diastolic Function in Heart Failure With Normal Ejection Fraction: A Comparative Doppler-Conductance Catheterization Study (2007) (538)
Cardiac Inflammation Contributes to Changes in the Extracellular Matrix in Patients With Heart Failure and Normal Ejection Fraction (2011) (475)
Cardiac troponin T in patients with clinically suspected myocarditis. (1997) (435)
Role of Left Ventricular Stiffness in Heart Failure With Normal Ejection Fraction (2008) (415)
Interferon-&bgr; Treatment Eliminates Cardiotropic Viruses and Improves Left Ventricular Function in Patients With Myocardial Persistence of Viral Genomes and Left Ventricular Dysfunction (2003) (395)
Diurnal, weekly and seasonal variation of sudden death. Population-based analysis of 24,061 consecutive cases. (2000) (366)
G-Protein–Coupled Receptor Mas Is a Physiological Antagonist of the Angiotensin II Type 1 Receptor (2005) (362)
Distal Microcirculatory Protection During Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction: A Randomized Controlled Trial (2005) (341)
Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio. (1999) (339)
Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. (2005) (322)
Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology (2009) (319)
The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements. (2005) (303)
Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. (1999) (301)
Procoagulant Soluble Tissue Factor Is Released From Endothelial Cells in Response to Inflammatory Cytokines (2005) (280)
Diastolic tissue Doppler indexes correlate with the degree of collagen expression and cross-linking in heart failure and normal ejection fraction. (2011) (275)
Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. (2008) (264)
The management of myocarditis. (2011) (263)
Parvovirus B19 Infection Mimicking Acute Myocardial Infarction (2003) (255)
Contributions of Inflammation and Cardiac Matrix Metalloproteinase Activity to Cardiac Failure in Diabetic Cardiomyopathy (2007) (249)
Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy. (1996) (240)
High Prevalence of Cardiac Parvovirus B19 Infection in Patients With Isolated Left Ventricular Diastolic Dysfunction (2005) (240)
Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. (2003) (233)
Long-Term Cardiac-Targeted RNA Interference for the Treatment of Heart Failure Restores Cardiac Function and Reduces Pathological Hypertrophy (2009) (226)
Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis. (1999) (224)
Detection of SARS-CoV-2 in Human Retinal Biopsies of Deceased COVID-19 Patients (2020) (215)
Complication Rate of Right Ventricular Endomyocardial Biopsy via the Femoral Approach: A Retrospective and Prospective Study Analyzing 3048 Diagnostic Procedures Over an 11-Year Period (2008) (214)
Immunological analysis of auto-antibodies against the adenine nucleotide translocator in dilated cardiomyopathy. (1985) (213)
Protective Role of Angiopoietin-1 in Endotoxic Shock (2005) (209)
Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy (2020) (201)
Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammatory cardiomyopathy. (1999) (198)
Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents (2005) (193)
Antibodies to ADP-ATP carrier--an autoantigen in myocarditis and dilated cardiomyopathy--impair cardiac function. (1990) (191)
Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy (2007) (185)
Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. (2000) (182)
Pretreatment with statin attenuates the cardiotoxicity of Doxorubicin in mice. (2009) (180)
Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy (2008) (178)
Laminin-&agr;4 and Integrin-Linked Kinase Mutations Cause Human Cardiomyopathy Via Simultaneous Defects in Cardiomyocytes and Endothelial Cells (2007) (173)
A Role for Toll-like Receptor 3 Variants in Host Susceptibility to Enteroviral Myocarditis and Dilated Cardiomyopathy* (2010) (168)
Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study). (2000) (164)
Human Coxsackie-Adenovirus Receptor Is Colocalized With Integrins αvβ3 and αvβ5 on the Cardiomyocyte Sarcolemma and Upregulated in Dilated Cardiomyopathy Implications for Cardiotropic Viral Infections (2001) (164)
Detection of viral SARS‐CoV‐2 genomes and histopathological changes in endomyocardial biopsies (2020) (158)
Quantification of Circulating Endothelial Progenitor Cells Using the Modified ISHAGE Protocol (2010) (148)
Antibodies to the ADP/ATP carrier, an autoantigen in myocarditis and dilated cardiomyopathy, penetrate into myocardial cells and disturb energy metabolism in vivo. (1989) (147)
Inhibition of p38 mitogen-activated protein kinase attenuates left ventricular dysfunction by mediating pro-inflammatory cardiac cytokine levels in a mouse model of diabetes mellitus (2006) (143)
Toll‐like receptor‐4 deficiency attenuates doxorubicin‐induced cardiomyopathy in mice (2008) (135)
Cardioprotective and Anti-Inflammatory Effects of Interleukin Converting Enzyme Inhibition in Experimental Diabetic Cardiomyopathy (2007) (131)
Angiotensin-(1–7) and the G Protein-Coupled Receptor Mas Are Key Players in Renal Inflammation (2009) (129)
Angiotensin II Type 1 Receptor Agonistic Antibodies Reflect Fundamental Alterations in the Uteroplacental Vasculature (2005) (126)
Laminin distribution and autoantibodies to laminin in dilated cardiomyopathy and myocarditis. (1989) (126)
Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy (2007) (123)
Tissue‐specific transcription pattern of the adenine nucleotide translocase isoforms in humans (1997) (122)
Antibody-mediated enhancement of calcium permeability in cardiac myocytes (1988) (120)
Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial). (2007) (119)
Cardiac fibroblasts support cardiac inflammation in heart failure (2014) (118)
Laminin-alpha4 and integrin-linked kinase mutations cause human cardiomyopathy via simultaneous defects in cardiomyocytes and endothelial cells. (2007) (118)
Multiple Interactions Between the Renin-Angiotensin and the Kallikrein-Kinin Systems: Role of ACE Inhibition and AT1 Receptor Blockade (2002) (114)
Interferon-Beta improves survival in enterovirus-associated cardiomyopathy. (2012) (113)
Transgenic activation of the kallikrein‐kinin system inhibits intramyocardial inflammation, endothelial dysfunction, and oxidative stress in experimental diabetic cardiomyopathy (2005) (112)
Ischemic injury in experimental stroke depends on angiotensin II (2002) (112)
Biglycan Is Required for Adaptive Remodeling After Myocardial Infarction (2008) (112)
Differential Expression of Matrix Metalloproteases in Human Fibroblasts with Different Origins (2012) (111)
Inhibition of Urokinase-Type Plasminogen Activator or Matrix Metalloproteinases Prevents Cardiac Injury and Dysfunction During Viral Myocarditis (2006) (107)
Collagen degradation in a murine myocarditis model: relevance of matrix metalloproteinase in association with inflammatory induction. (2002) (106)
Myocardial proteases and matrix remodeling in inflammatory heart disease. (2006) (104)
Human coxsackie-adenovirus receptor is colocalized with integrins alpha(v)beta(3) and alpha(v)beta(5) on the cardiomyocyte sarcolemma and upregulated in dilated cardiomyopathy: implications for cardiotropic viral infections. (2001) (103)
Impact of time to treatment on myocardial reperfusion and infarct size with primary percutaneous coronary intervention for acute myocardial infarction (from the EMERALD Trial). (2007) (102)
Dilated cardiomyopathy (1992) (102)
Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene (2004) (101)
Gene Deletion of the Kinin Receptor B1 Attenuates Cardiac Inflammation and Fibrosis During the Development of Experimental Diabetic Cardiomyopathy (2009) (101)
Human Apolipoprotein A-I Gene Transfer Reduces the Development of Experimental Diabetic Cardiomyopathy (2008) (99)
Induction of Coxsackievirus-Adenovirus–Receptor Expression During Myocardial Tissue Formation and Remodeling: Identification of a Cell-to-Cell Contact–Dependent Regulatory Mechanism (2003) (96)
The Frontier stent registry: safety and feasibility of a novel dedicated stent for the treatment of bifurcation coronary artery lesions. (2005) (95)
Renin Inhibition Improves Cardiac Function and Remodeling After Myocardial Infarction Independent of Blood Pressure (2008) (95)
Autoantibodies against human ventricular myosin in sera of patients with acute and chronic myocarditis. (1994) (95)
Evidence of SARS-CoV-2 mRNA in endomyocardial biopsies of patients with clinically suspected myocarditis tested negative for COVID-19 in nasopharyngeal swab (2020) (94)
The endothelin receptor blocker bosentan inhibits doxorubicin-induced cardiomyopathy. (2007) (93)
Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets? (2007) (92)
Alterations in myocardial tissue factor expression and cellular localization in dilated cardiomyopathy. (2005) (91)
Diltiazem treatment prevents diastolic heart failure in mice with familial hypertrophic cardiomyopathy (2006) (91)
3 Tesla MRI‐Detected Brain Lesions after Pulmonary Vein Isolation for Atrial Fibrillation: Results of the MACPAF Study (2013) (88)
Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-β treatment in patients with chronic viral cardiomyopathy (2016) (88)
[Prospective study of the incidence, pathogenesis and therapy of spontaneous, by coronary angiography diagnosed coronary artery dissection]. (1998) (88)
Reduced Degradation of the Chemokine MCP-3 by Matrix Metalloproteinase-2 Exacerbates Myocardial Inflammation in Experimental Viral Cardiomyopathy (2011) (85)
Cardiomyocyte‐restricted over‐expression of C‐type natriuretic peptide prevents cardiac hypertrophy induced by myocardial infarction in mice (2007) (84)
Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial (2017) (84)
Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis (2010) (84)
Tissue factor expression pattern in human non-small cell lung cancer tissues indicate increased blood thrombogenicity and tumor metastasis. (2008) (83)
Cardiac phenotype and angiotensin II levels in AT1a, AT1b, and AT2 receptor single, double, and triple knockouts. (2010) (83)
Toll-Like Receptor-4 Modulates Survival by Induction of Left Ventricular Remodeling after Myocardial Infarction in Mice1 (2008) (83)
Antioxidative treatment inhibits the release of thrombogenic tissue factor from irradiation- and cytokine-induced endothelial cells. (2007) (82)
Description of a local cardiac adiponectin system and its deregulation in dilated cardiomyopathy. (2006) (82)
Dilated cardiomyopathy (2019) (82)
Circulating Rather Than Cardiac Angiotensin-(1-7) Stimulates Cardioprotection After Myocardial Infarction (2010) (82)
Global strain rate imaging for the estimation of diastolic function in HFNEF compared with pressure-volume loop analysis. (2010) (81)
Vascular-Protective Effects of High-Density Lipoprotein Include the Downregulation of the Angiotensin II Type 1 Receptor (2009) (79)
Chromosomally integrated human herpesvirus 6 in heart failure: prevalence and treatment (2015) (78)
Carvedilol improves left ventricular function in murine coxsackievirus‐induced acute myocarditis Association with reduced myocardial interleukin‐1β and MMP‐8 expression and a modulated immune response (2005) (78)
Endothelial dysfunction through genetic deletion or inhibition of the G protein-coupled receptor Mas: a new target to improve endothelial function (2007) (78)
Prevention of Cardiac Dysfunction in Acute Coxsackievirus B3 Cardiomyopathy by Inducible Expression of a Soluble Coxsackievirus-Adenovirus Receptor (2009) (77)
Impact of HDL on adipose tissue metabolism and adiponectin expression. (2010) (77)
TRIF Is a Critical Survival Factor in Viral Cardiomyopathy (2011) (77)
Enhancement of the endothelial NO synthase attenuates experimental diastolic heart failure (2009) (75)
Angiotensin metabolites can stimulate receptors of the Mas-related genes family (2008) (75)
Upregulation of bradykinin B1‐receptor expression after myocardial infarction (2000) (75)
Prevalence of erythrovirus genotypes in the myocardium of patients with dilated cardiomyopathy (2008) (75)
Preamplification techniques for real-time RT-PCR analyses of endomyocardial biopsies (2008) (75)
Long-term risk of recurrence, morbidity and mortality in giant cell myocarditis. (2015) (74)
Cdc2-Like Kinases and DNA Topoisomerase I Regulate Alternative Splicing of Tissue Factor in Human Endothelial Cells (2009) (74)
Role of Heart Rate Reduction in the Prevention of Experimental Heart Failure: Comparison Between If-Channel Blockade and &bgr;-Receptor Blockade (2012) (73)
Genomic expression profiling of human inflammatory cardiomyopathy (DCMi) suggests novel therapeutic targets (2006) (72)
Successive Action of Meprin A and Neprilysin Catabolizes B-Type Natriuretic Peptide (2007) (72)
Left ventricular dysfunction induced by nonsevere idiopathic pulmonary arterial hypertension: a pressure-volume relationship study. (2012) (71)
Angiotensin-(1–7) stimulates hematopoietic progenitor cells in vitro and in vivo (2009) (70)
Immunoglobulin G3 cardiac myosin autoantibodies correlate with left ventricular dysfunction in patients with dilated cardiomyopathy: immunoglobulin G3 and clinical correlates. (2002) (69)
New Concepts in Viral Heart Disease (1988) (69)
Immunochemical characterization of the adenine nucleotide translocator. Organ specificity and conformation specificity. (1984) (68)
Interferon beta modulates endothelial damage in patients with cardiac persistence of human parvovirus b19 infection. (2010) (68)
Immunohistochemistry in dilated cardiomyopathy. (1995) (67)
Long-term outcome of patients with virus-negative chronic myocarditis or inflammatory cardiomyopathy after immunosuppressive therapy (2016) (65)
Expression of functional T‐cell markers and T‐cell receptor Vbeta repertoire in endomyocardial biopsies from patients presenting with acute myocarditis and dilated cardiomyopathy (2011) (65)
Accelerated Mitochondrial Adenosine Diphosphate/Adenosine Triphosphate Transport Improves Hypertension-Induced Heart Disease (2007) (65)
Development of diastolic heart failure in a 6-year follow-up study in patients after acute myocarditis (2010) (64)
High-density lipoprotein at the interface of type 2 diabetes mellitus and cardiovascular disorders. (2010) (62)
Selective PDE5A inhibition with sildenafil rescues left ventricular dysfunction, inflammatory immune response and cardiac remodeling in angiotensin II-induced heart failure in vivo (2012) (62)
Adiponectin protects against Toll-like receptor 4-mediated cardiac inflammation and injury. (2013) (61)
Immunohistological characterization of infiltrating lymphocytes in biopsies of patients with clinically suspected dilated cardiomyopathy. (1994) (61)
Digital image analysis system for the quantification of infiltrates and cell adhesion molecules in inflammatory cardiomyopathy. (2002) (61)
Myocarditis in children. (2010) (60)
Differential myocardial abundance of collagen type I and type III mRNA in dilated cardiomyopathy: effects of myocardial inflammation. (1998) (60)
New Echocardiographic Findings Correlate with Intramyocardial Inflammation in Endomyocardial Biopsies of Patients with Acute Myocarditis and Inflammatory Cardiomyopathy (2013) (59)
Selective regulation of cardiac organic cation transporter novel type 2 (OCTN2) in dilated cardiomyopathy. (2011) (59)
Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis. (2013) (59)
Transfer of human myocarditis into severe combined immunodeficiency mice. (1994) (58)
Antimyosin scintigraphy and immunohistologic analysis of endomyocardial biopsy in patients with clinically suspected myocarditis--evidence of myocardial cell damage and inflammation in the absence of histologic signs of myocarditis. (1998) (58)
Low-dose treatment with atorvastatin leads to anti-oxidative and anti-inflammatory effects in diabetes mellitus. (2007) (58)
The angiotensin-(1-7) receptor agonist AVE0991 is cardioprotective in diabetic rats. (2008) (57)
Relation between circulating angiotensin II type 1 receptor agonistic autoantibodies and soluble fms-like tyrosine kinase 1 in the pathogenesis of preeclampsia. (2006) (57)
Cell-mediated cytotoxicity in hearts with dilated cardiomyopathy: correlation with interstitial fibrosis and foci of activated T lymphocytes. (1997) (56)
Rate-dependence of QT dispersion and the QT interval: comparison of atrial pacing and exercise testing. (2000) (56)
Neuropsychological Effects of MRI-Detected Brain Lesions After Left Atrial Catheter Ablation for Atrial Fibrillation: Long-Term Results of the MACPAF Study (2013) (56)
Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction. (2013) (55)
Myocardial bradykinin B2‐receptor expression at different time points after induction of myocardial infarction (2000) (55)
Myocardial Remodeling in Viral Heart Disease: Possible Interactions Between Inflammatory Mediators and MMP-TIMP System (2004) (55)
Interleukin-6 receptor inhibition modulates the immune reaction and restores titin phosphorylation in experimental myocarditis (2014) (55)
Matricellular Signaling Molecule CCN1 Attenuates Experimental Autoimmune Myocarditis by Acting as a Novel Immune Cell Migration Modulator (2010) (54)
Cardiovascular phenotype of mice lacking all three subtypes of angiotensin II receptors (2008) (53)
Autoimmunological features in inflammatory cardiomyopathy (2007) (53)
The bradykinin B1 receptor contributes to the cardioprotective effects of AT1 blockade after experimental myocardial infarction. (2004) (52)
NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis (2017) (52)
Improved diagnosis of idiopathic giant cell myocarditis and cardiac sarcoidosis by myocardial gene expression profiling. (2014) (52)
Differential Aspects of Endothelial Function of the Coronary Microcirculation Considering Myocardial Virus Persistence, Endothelial Activation, and Myocardial Leukocyte Infiltrates (2005) (52)
LXR agonism improves TNF-α-induced endothelial dysfunction in the absence of its cholesterol-modulating effects. (2014) (51)
Long-term follow-up of the randomised controlled trial to evaluate the safety and efficacy of the zotarolimus-eluting driver coronary stent in de novo native coronary artery lesions: five year outcomes in the ENDEAVOR II study. (2010) (51)
Phased Chest and Abdominal Compression-Decompression Versus Conventional Cardiopulmonary Resuscitation in Out-of-Hospital Cardiac Arrest (2001) (51)
A distinct subgroup of cardiomyopathy patients characterized by transcriptionally active cardiotropic erythrovirus and altered cardiac gene expression (2013) (51)
Long noncoding RNA MALAT1-derived mascRNA is involved in cardiovascular innate immunity. (2016) (51)
CCN1: a novel inflammation-regulated biphasic immune cell migration modulator (2012) (51)
Disturbance of myocardial energy metabolism in experimental virus myocarditis by antibodies against the adenine nucleotide translocator. (1999) (51)
Comparison of the diagnostic potential of four echocardiographic stress tests shortly after acute myocardial infarction: submaximal exercise, transesophageal atrial pacing, dipyridamole, and dobutamine-atropine. (1996) (50)
Intracardiac thrombosis: patient-related and device-related factors. (1995) (50)
Mesenchymal Stromal Cells but Not Cardiac Fibroblasts Exert Beneficial Systemic Immunomodulatory Effects in Experimental Myocarditis (2012) (49)
Alteration of the cytosolic-mitochondrial distribution of high-energy phosphates during global myocardial ischemia may contribute to early contractile failure. (1994) (49)
Treatment of chronic myocarditis with corticosteroids. (1995) (48)
Adiponectin expression in patients with inflammatory cardiomyopathy indicates favourable outcome and inflammation control. (2011) (48)
NOX2 amplifies acetaldehyde-mediated cardiomyocyte mitochondrial dysfunction in alcoholic cardiomyopathy (2016) (48)
Plasma ACE2 activity is an independent prognostic marker in Chagas' disease and equally potent as BNP. (2010) (48)
Transcription of the adenine nucleotide translocase isoforms in various types of tissues in the rat. (1999) (47)
Antibody-mediated imbalance of myocardial energy metabolism. A causal factor of cardiac failure? (1995) (47)
High leptin and resistin expression in chronic heart failure: adverse outcome in patients with dilated and inflammatory cardiomyopathy (2012) (47)
The antigenic characteristics and the significance of the adenine nucleotide translocator as a major autoantigen to antimitochondrial antibodies in dilated cardiomyopathy. (1985) (46)
The role of the renal kallikrein–kinin system in diabetic nephropathy (2007) (46)
Increased plasma retinol binding protein 4 levels in patients with inflammatory cardiomyopathy (2009) (46)
Role of the phosphatidylinositol 3-kinase/protein kinase B pathway in regulating alternative splicing of tissue factor mRNA in human endothelial cells. (2009) (46)
Viral myocarditis and coagulopathy: increased tissue factor expression and plasma thrombogenicity. (2008) (46)
Myeloid differentiation factor-88 contributes to TLR9-mediated modulation of acute coxsackievirus B3-induced myocarditis in vivo. (2010) (46)
Interleukin-23 Deficiency Leads to Impaired Wound Healing and Adverse Prognosis After Myocardial Infarction (2014) (45)
Regulation of pro-angiogenic tissue factor expression in hypoxia-induced human lung cancer cells. (2013) (45)
Immunomodulation and matrix metalloproteinases in viral myocarditis. (2010) (45)
Cardiac-targeted delivery of regulatory RNA molecules and genes for the treatment of heart failure (2010) (44)
Viral heart disease: molecular diagnosis, clinical prognosis, and treatment strategies (2004) (44)
Innate Immune Interleukin-1 Receptor–Associated Kinase 4 Exacerbates Viral Myocarditis by Reducing CCR5+CD11b+ Monocyte Migration and Impairing Interferon Production (2013) (43)
Endothelium-Dependent Flow-Mediated Vasodilation of Systemic Arteries Is Impaired in Patients With Myocardial Virus Persistence (2003) (42)
Identification of serotype-specific and nonserotype-specific B-cell epitopes of coxsackie B virus using synthetic peptides. (1994) (42)
Elevated Sera sST2 Is Associated With Heart Failure in Men ≤50 Years Old With Myocarditis (2019) (42)
Enteroviral Heart Disease: Diagnosis by In Situ Hybridization (1988) (41)
Regulation of cardiac bradykinin B1- and B2-receptor mRNA in experimental ischemic, diabetic, and pressure-overload-induced cardiomyopathy. (2002) (41)
Troponin elevation in acute ischemic stroke (TRELAS) - protocol of a prospective observational trial (2011) (40)
[Immunosuppressive therapy of myocarditis?]. (1992) (40)
Adiponectin modulates NK‐cell function (2013) (39)
[Acute myocardial infarct caused by a muscle bridge of the anterior interventricular ramus: complicated course with vascular perforation after stent implantation]. (1997) (39)
Analysis of endomyocardial biopsies in suspected myocarditis--diagnostic value of left versus right ventricular biopsy. (2014) (39)
Chronic inflammation in the myocardium of patients with clinically suspected dilated cardiomyopathy. (1994) (39)
Sodium-hydrogen exchange inhibition: novel strategy to prevent myocardial injury following ischemia and reperfusion. (1999) (39)
Endothelial dysfunction of peripheral arteries in patients with immunohistologically confirmed myocardial inflammation correlates with endothelial expression of human leukocyte antigens and adhesion molecules in myocardial biopsies. (2002) (39)
Human Cardiac-Derived Adherent Proliferating Cells Reduce Murine Acute Coxsackievirus B3-Induced Myocarditis (2011) (39)
The effect of clopidogrel on platelet activity in patients with and without type-2 diabetes mellitus: a comparative study (2015) (39)
Achievement of guideline-defined treatment goals in primary care: the German Coronary Risk Management (CoRiMa) study. (2007) (38)
ADP induced platelet degranulation in healthy individuals is reduced by clopidogrel after pretreatment with atorvastatin (2004) (38)
Immunoelectrophoretic characterization of the ADPATP carrier from heart, kidney, and liver (1985) (38)
Methylprednisolone in chronic myocarditis. (1994) (37)
miRNA as activity markers in Parvo B19 associated heart disease (2012) (37)
Intramyocardial inflammation predicts adverse outcome in patients with cardiac AL amyloidosis (2018) (37)
Single-target RNA interference for the blockade of multiple interacting proinflammatory and profibrotic pathways in cardiac fibroblasts. (2014) (37)
Dysfunction of the ADP/ATP carrier as a causative factor for the disturbance of the myocardial energy metabolism in dilated cardiomyopathy. (1992) (37)
Late prosthetic valve endocarditis. (1995) (36)
An isoform shift in the cardiac adenine nucleotide translocase expression alters the kinetic properties of the carrier in dilated cardiomyopathy (2006) (36)
The shift in the myocardial adenine nucleotide translocator isoform expression pattern is associated with an enteroviral infection in the absence of an active T-cell dependent immune response in human inflammatory heart disease. (2000) (36)
Immunosuppressive therapy for myocarditis. (1995) (36)
Down-regulation of endothelial TLR4 signalling after apo A-I gene transfer contributes to improved survival in an experimental model of lipopolysaccharide-induced inflammation (2010) (36)
Impaired Endothelial Regeneration Through Human Parvovirus B19-Infected Circulating Angiogenic Cells in Patients With Cardiomyopathy. (2015) (35)
Immunomodulation by interleukin-4 suppresses matrix metalloproteinases and improves cardiac function in murine myocarditis. (2007) (35)
Elevated NT-ProBNP levels in patients with increased left ventricular filling pressure during exercise despite preserved systolic function. (2005) (35)
Genome–environment interactions in the molecular pathogenesis of dilated cardiomyopathy (2005) (35)
The Ca-channel as cardiac autoantigen. (1991) (35)
Multimodality imaging approach in the diagnosis of chronic myocarditis with preserved left ventricular ejection fraction (MCpEF): The role of 2D speckle-tracking echocardiography. (2017) (35)
Is parvovirus B19 the cause for autoimmunity against the angiotensin II type receptor? (2007) (34)
Adenine nucleotide translocator in dilated cardiomyopathy: pathophysiological alterations in expression and function. (1997) (34)
The role of sensitized T-cells in myocarditis and dilated cardiomyopathy. (1996) (34)
Improved Learning and Memory in Aged Mice Deficient in Amyloid β-Degrading Neutral Endopeptidase (2009) (34)
Left ventricular enlargement in coxsackievirus-B3 induced chronic myocarditis--ongoing inflammation and an imbalance of the matrix degrading system. (2010) (34)
The role of the ADP/ATP carrier in the pathogenesis of viral heart disease. (1995) (34)
Annual distribution of ventricular tachycardias and ventricular fibrillation (2003) (33)
Myocardial overexpression of adenine nucleotide translocase 1 ameliorates diabetic cardiomyopathy in mice (2009) (33)
Association of tissue-factor upregulation in squamous-cell carcinoma of the lung with increased tissue factor in circulating blood. (2005) (33)
Myocardial expression of rat bradykinin receptors and two tissue kallikrein genes in experimental diabetes. (1999) (33)
The utility of speckle tracking imaging in the diagnostic of acute myocarditis, as proven by endomyocardial biopsy. (2013) (33)
New Function for an Old Enzyme: NEP Deficient Mice Develop Late-Onset Obesity (2010) (32)
Presence of perforin in endomyocardial biopsies of patients with inflammatory cardiomyopathy predicts poor outcome (2014) (32)
Chronic inhibition of p38MAPK improves cardiac and endothelial function in experimental diabetes mellitus. (2007) (32)
Protection against oxidative stress in diabetic rats: role of angiotensin AT(1) receptor and beta 1-adrenoceptor antagonism. (2005) (32)
Natriuretic peptide system in fetal heart and circulation. (2002) (32)
sICAM-1 correlates with myocardial ICAM-1 expression in dilated cardiomyopathy. (2003) (32)
Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy. (2003) (32)
Inflammation, ECG changes and pericardial effusion (2006) (32)
Upregulation of tissue factor expression and thrombogenic activity in human aortic smooth muscle cells by irradiation, rapamycin and paclitaxel. (2008) (31)
Current insights into the pathogenesis, diagnosis and therapy of inflammatory cardiomyopathy. (2003) (31)
Late potentials and heart rate variability in heart muscle disease. (1994) (31)
Remodeling of the cardiac extracellular matrix differs between volume- and pressure-overloaded ventricles and is specific for each heart valve lesion. (2003) (31)
Antibodies against ADP-ATP carrier enhance Ca2+ current in isolated cardiac myocytes. (1988) (31)
Mesenchymal Stem Cells and Inflammatory Cardiomyopathy: Cardiac Homing and Beyond (2011) (31)
Differential Cardiac MicroRNA Expression Predicts the Clinical Course in Human Enterovirus Cardiomyopathy (2014) (31)
Improvement of defective sarcoplasmic reticulum Ca2+ transport in diabetic heart of transgenic rats expressing the human kallikrein‐1 gene (2004) (31)
Mapping of antigenic determinants of the adenine-nucleotide translocator and coxsackie B3 virus with synthetic peptides: use for the diagnosis of viral heart disease. (1993) (30)
Myocarditis: early biopsy allows for tailored regenerative treatment. (2012) (30)
Relation of ANP and BNP to their N‐terminal fragments in fetal circulation: evidence for enhanced neutral endopeptidase activity and resistance of BNP to neutral endopeptidase in the fetus (2004) (30)
Impact of Telemedical Care and Monitoring on Morbidity in Mild to Moderate Chronic Heart Failure (2008) (30)
New perspective on the tissue kallikrein-kinin system in myocardial infarction: role of angiogenesis and cardiac regeneration. (2008) (29)
Increased Left Ventricular Stiffness Impairs Exercise Capacity in Patients with Heart Failure Symptoms Despite Normal Left Ventricular Ejection Fraction (2011) (29)
Aggravation of left ventricular dysfunction in patients with biopsy-proven cardiac human herpesvirus A and B infection. (2015) (29)
The Myocardial Expression of the Adenine Nucleotide Translocator Isoforms is Specifically Altered in Dilated Cardiomyopathy (2000) (29)
Cardioprotective mechanisms of the kallikrein–kinin system in diabetic cardiopathy (2006) (29)
Enhancement of endothelial nitric oxide synthase production reverses vascular dysfunction and inflammation in the hindlimbs of a rat model of diabetes (2008) (29)
Analysis of the coxsackievirus B-adenovirus receptor gene in patients with myocarditis or dilated cardiomyopathy. (2002) (29)
Mesh ablator vs. cryoballoon pulmonary vein ablation of symptomatic paroxysmal atrial fibrillation: results of the MACPAF study. (2012) (29)
Dose-Related Effects of ACE Inhibition in Man: Quinapril in Patients with Moderate Congestive Heart Failure (1994) (29)
829-5 Primary angioplasty in acute myocardial infarction with distal protection of the microcirculation: Principal results from the prospective, randomized EMERALD trial (2004) (28)
The mitochondrial adenine nucleotide translocator is an antigen in primary biliary cirrhosis. (1983) (28)
Simultaneous estimation of NT-proBNP on top to mitral flow Doppler echocardiography as an accurate strategy to diagnose diastolic dysfunction in HFNEF. (2011) (28)
Effects of the Cdc2-like kinase-family and DNA topoisomerase I on the alternative splicing of eNOS in TNF-α-stimulated human endothelial cells (2008) (28)
Adenine nucleotide translocase in the focus of cardiovascular diseases. (2007) (28)
Cardiac Arrest and Ventricular Tachycardia in Japanese-Type Apical Hypertrophic Cardiomyopathy (2006) (28)
Immunomodulatory treatment strategies in inflammatory cardiomyopathy: current status and future perspectives (2004) (28)
Overexpression of alternatively spliced tissue factor induces the pro-angiogenic properties of murine cardiomyocytic HL-1 cells. (2011) (28)
NS1 Specific CD8+ T-Cells with Effector Function and TRBV11 Dominance in a Patient with Parvovirus B19 Associated Inflammatory Cardiomyopathy (2008) (28)
Potential role of antibodies against cardiac Kv channel-interacting protein 2 in dilated cardiomyopathy. (2008) (27)
Brain natriuretic peptide predicts survival in Chagas’ disease more effectively than atrial natriuretic peptide (2005) (27)
How to perform an endomyocardial biopsy? (2015) (27)
Assessment of multiple displacement amplification for polymorphism discovery and haplotype determination at a highly polymorphic locus, MC1R (2005) (27)
Prognostic Value of Natriuretic Peptides in Chagas’ Disease: A 3-Year Follow-Up Investigation (2007) (27)
Familial Recurrent Myocarditis Triggered by Exercise in Patients With a Truncating Variant of the Desmoplakin Gene (2020) (27)
Disturbance of the myocardial energy metabolism in dilated cardiomyopathy due to autoimmunological mechanisms. (1993) (26)
Update 2001¶Myokarditis – Kardiomyopathie (2001) (26)
Biomolecular Changes in Dilated Cardiomyopathy (1990) (26)
The possible value of synthetic peptides in the diagnosis and therapy of myocarditis and dilated cardiomyopathy. (1991) (26)
AT1 receptor blockade increases cardiac bradykinin via neutral endopeptidase after induction of myocardial infarction in rats (2002) (26)
Fibrosis rather than blood pressure determines cardiac BNP expression in mice (2003) (26)
Impaired Function of Dendritic Cells Deficient in Angiotensin II Type 1 Receptors (2010) (26)
Adaptive immune responses against parvovirus B19 in patients with myocardial disease. (2009) (25)
Feasibility and safety of left ventricular endomyocardial biopsy via transradial access: Technique and initial experience (2015) (25)
Enzymatic analysis and collagen content in endomyocardial biopsy samples of patients with congestive cardiomyopathy of unknown etiology (1980) (25)
Globular adiponectin but not full-length adiponectin induces increased procoagulability in human endothelial cells. (2008) (25)
Parvovirus B19 profiles in patients presenting with acute myocarditis and chronic dilated cardiomyopathy. (2008) (25)
Fractalkine in human inflammatory cardiomyopathy (2011) (24)
CAR-diology—a virus receptor in the healthy and diseased heart (2009) (24)
Platelet activation is increased in patients with cardiomyopathy: myocardial inflammation and platelet reactivity (2002) (24)
Ionizing radiation induces upregulation of cellular procoagulability and tissue factor expression in human peripheral blood mononuclear cells. (2007) (24)
Parvovirus B 19 Infection Mimicking Acute Myocardial Infarction (2003) (24)
Impairment of myocardial calcium homeostasis by antibodies against the adenine nucleotide translocator. (1999) (23)
Doxorubicin cardiomyopathy-induced inflammation and apoptosis are attenuated by gene deletion of the kinin B1 receptor (2008) (23)
Cardiac kinin level in experimental diabetes mellitus: role of kininases. (2003) (23)
Angiotensin deficiency in mice leads to dilated cardiomyopathy. (2004) (23)
Advances in the immunohistological diagnosis of inflammatory cardiomyopathy (2002) (23)
Postmenopausal women have an increased maximal platelet reactivity compared to men despite dual antiplatelet therapy (2012) (22)
Proof of SARS-CoV-2 genomes in endomyocardial biopsy with latency after acute infection (2020) (22)
Evolutionary History of Endogenous Human Herpesvirus 6 Reflects Human Migration out of Africa (2020) (22)
Cytotoxic perforin+ and TIA‐1+ infiltrates are associated with cell adhesion molecule expression in dilated cardiomyopathy (2003) (22)
Immunoadsorption and subsequent immunoglobulin substitution decreases myocardial gene expression of desmin in dilated cardiomyopathy (2007) (22)
Adventitial VEGF165 gene transfer prevents lumen loss through induction of positive arterial remodeling after PTCA in porcine coronary arteries. (2006) (22)
Cardiac iron concentration in relation to systemic iron status and disease severity in non‐ischaemic heart failure with reduced ejection fraction (2020) (22)
The effect of ACE inhibition on myocardial energy metabolism. (1990) (21)
Protective Function of STAT3 in CVB3-Induced Myocarditis (2012) (21)
Effect of adventitial VEGF(165) gene transfer on vascular thickening after coronary artery balloon injury. (2003) (21)
Immunosuppression with an interleukin-2 fusion protein leads to improved LV function in experimental ischemic cardiomyopathy. (2010) (21)
Renin inhibitors, clinical experience (2008) (21)
Hemodynamic characterization of left ventricular function in experimental coxsackieviral myocarditis: effects of carvedilol and metoprolol. (2004) (21)
Transgenic overexpression of adenine nucleotide translocase 1 protects ischemic hearts against oxidative stress (2016) (21)
Cardiac function and remodeling is attenuated in transgenic rats expressing the human kallikrein-1 gene after myocardial infarction. (2006) (21)
[Dilated cardiomyopathy--a chronic myocarditis? Immunohistological characterization of lymphocytic infiltrates]. (1992) (21)
The genetic deletion of Mas abolishes salt induced hypertension in mice. (2012) (20)
Kinins in cardiac inflammation and regeneration: Insights from ischemic and diabetic cardiomyopathy (2010) (20)
Immunohistological detection of Parvovirus B19 capsid proteins in endomyocardial biopsies from dilated cardiomyopathy patients. (2008) (20)
High incidence of cardiac dysfunction and response to antiviral treatment in patients with chronic hepatitis C virus infection (2017) (19)
Intramuscular gene transfer of fibroblast growth factor-1 using improved pCOR plasmid design stimulates collateral formation in a rabbit ischemic hindlimb model (2006) (19)
The mitochondrial respiratory chain has a critical role in the antiviral process in Coxsackievirus B3-induced myocarditis (2012) (19)
Bivalirudin inhibits periprocedural platelet function and tissue factor expression of human smooth muscle cells. (2013) (19)
Lack in treatment options for virus-induced inflammatory cardiomyopathy: can iPS-derived cardiomyocytes close the gap? (2014) (19)
Cardiac SARS-CoV-2 infection is associated with pro-inflammatory transcriptomic alterations within the heart (2021) (19)
Plasminogen activator inhibitor-1 reduces cardiac fibrosis and promotes M2 macrophage polarization in inflammatory cardiomyopathy (2021) (18)
Prognostic value of circulating levels of stem cell growth factor beta (SCGF beta) in patients with Chagas' disease and idiopathic dilated cardiomyopathy. (2013) (18)
Significance of the adenine nucleotide translocator in the pathogenesis of viral heart disease (1996) (18)
The forkhead transcription factor Foxo3 negatively regulates natural killer cell function and viral clearance in myocarditis (2018) (18)
Images in cardiovascular medicine. Myocardial infarction caused by occlusion of Cabrol conduit graft. (2005) (18)
Myocarditis and inflammatory cardiomyopathy: from diagnosis to treatment. (2015) (18)
Adenine nucleotide translocator in dilated cardiomyopathy: Pathophysiological alterations in expression and function (2004) (18)
Annual distribution of ventricular tachycardias and ventricular fibrillation. (2004) (18)
Therapeutic implications of a combined diagnostic workup including endomyocardial biopsy in an all‐comer population of patients with heart failure: a retrospective analysis (2018) (18)
Upregulation of the cardiac bradykinin B2 receptors after myocardial infarction. (1999) (17)
The significance of autoantibodies against the ADP/ATP carrier for the pathogenesis of myocarditis and dilated cardiomyopathy — clinical and experimental data (2004) (17)
Fetal, neonatal cord, and maternal plasma concentrations of angiotensin‐converting enzyme (ACE) (2002) (17)
Myocarditis--cardiomyopathy. Consensus Report of the German Association for Internal Medicine, presented at the 100th annual meeting, Wiesbaden, 13 April 1994. (1996) (17)
Cardiac autoantibodies in viral myocarditis. (2005) (17)
Roles of T cells in coxsackievirus B-induced disease. (1997) (17)
Adenine nucleotide translocase 1 overexpression protects cardiomyocytes against hypoxia via increased ERK1/2 and AKT activation. (2016) (17)
Cardiovascular consequences of viral infections: from COVID to other viral diseases (2021) (16)
The amount of fibrinogen-positive platelets predicts the occurrence of in-stent restenosis. (2008) (16)
Autoantibodies Against the Adenine Nucleotide Translocator in Myocarditis and Dilated Cardiomyopathy (1984) (16)
Impact of myocardial inflammation on cytosolic and mitochondrial creatine kinase activity and expression (2009) (16)
‘Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis’ [Eur Heart J 2011;32(17):2168-2178, doi:10.1093/eurheartj/ehq467] (2013) (16)
Opposite regulation of brain and C-type natriuretic peptides in the streptozotocin-diabetic cardiopathy. (2000) (16)
Stroke risk associated with balloon based catheter ablation for atrial fibrillation: Rationale and design of the MACPAF Study (2010) (16)
Evaluation of Immunohistological Data for the Diagnosis of Myocarditis (1988) (16)
[Emergency heart valve replacement after acute cerebral embolism during florid endocarditis]. (1998) (16)
CCR5del32 genotype in human enteroviral cardiomyopathy leads to spontaneous virus clearance and improved outcome compared to wildtype CCR5 (2018) (16)
Safety and reliability of the insertable Reveal XT recorder in patients undergoing 3 Tesla brain magnetic resonance imaging. (2011) (16)
The Role of Immune Mechanisms in Cardiovascular Disease (1997) (16)
Prehospital versus periprocedural abciximab in ST -elevation myocardial infarction treated by percutaneous coronary intervention (2008) (16)
Effect of ionizing radiation on cellular procoagulability and co-ordinated gene alterations. (2007) (16)
Endomyocardial biopsy and ultrastructural changes in dilated cardiomyopathy: taking a 'deeper' look into patients' prognosis. (2015) (15)
Expression of C-Type Natriuretic Peptide in Human Placenta and Myometrium in Normal Pregnancies and Pregnancies Complicated by Intrauterine Growth Retardation (2002) (15)
Viral Myocarditis (2009) (15)
New concepts in viral heart disease : virology, immunology, and clinical management (1988) (15)
Coronary vasospasm–induced acute diastolic dysfunction in a patient with Raynaud’s phenomenon (2006) (15)
Overview on chronic viral cardiomyopathy/chronic myocarditis. (2006) (15)
Angiotensin AT2 receptor deficiency after myocardial infarction (2007) (15)
Is myocardial Na+/Ca2+ exchanger transcription a marker for different stages of myocardial dysfunction? Quantitative polymerase chain reaction of the messenger RNA in endomyocardial biopsies of patients with heart failure. (2000) (15)
Effect on the myocardial energy metabolism of angiotensin-converting enzyme inhibition in chronic heart failure. (1990) (15)
Effects of mesenchymal stromal cells on diabetic cardiomyopathy. (2011) (15)
Inhibition of the adenine nucleotide translocator by organ specific autoantibodies in primary biliary cirrhosis. (1984) (15)
A thrombocyte-induced myocardial dysfunction in the ischemic and reperfused guinea pig heart is mediated by reactive oxygen species. (2000) (15)
MicroRNA profiling as a novel diagnostic tool for identification of patients with inflammatory and/or virally induced cardiomyopathies (2020) (14)
Diastolic heart failure and LV dyssynchrony. (2012) (14)
Myocardial viability evaluation using magnetocardiography in patients with coronary artery disease (2004) (14)
Platelet activation and thrombus formation relates to the presence of myocardial inflammation in patients with cardiomyopathy. (2014) (14)
Mesenchymal stromal cells: a promising cell source for the treatment of inflammatory cardiomyopathy. (2011) (14)
Prolonged application of clopidogrel reduces inflammation after percutaneous coronary intervention in the porcine model. (2007) (14)
Adiponectin attenuates profibrotic extracellular matrix remodeling following cardiac injury by up‐regulating matrix metalloproteinase 9 expression in mice (2017) (14)
Diadenosine polyphosphates Ap3A and Ap4A, but not Ap5A or Ap6A, induce proliferation of vascular smooth muscle cells. (2008) (14)
Viral Myocarditis—From Pathophysiology to Treatment (2021) (14)
Identification of novel antigens contributing to autoimmunity in cardiovascular diseases. (2016) (13)
The Angiotensin-(1-7) Receptor Agonist AVE0991 Dominates the Circadian Rhythm and Baroreflex in Spontaneously Hypertensive Rats (2007) (13)
Cardiac Migration of Endogenous Mesenchymal Stromal Cells in Patients with Inflammatory Cardiomyopathy (2015) (13)
Leptin and resistin induce increased procoagulability in diabetes mellitus. (2011) (13)
Laminin- 4 and Integrin-Linked Kinase Mutations Cause Human Cardiomyopathy Via Simultaneous Defects in Cardiomyocytes and Endothelial Cells (2007) (13)
Giant-cell myocarditis in a patient presenting with dilated cardiomyopathy and ventricular tachycardias treated by immunosuppression: a case report. (2008) (13)
[Dilated cardiomyopathy--a chronic myocarditis? New aspects on diagnosis and therapy]. (1993) (12)
[Autoantibodies against cardiac myosin in patients with myocarditis and dilated cardiomyopathy]. (1995) (12)
High-density lipoprotein-raising strategies: update 2010. (2010) (12)
Parvovirus B19–Associated Active Myocarditis With Biventricular Thrombi Results of Endomyocardial Biopsy Investigations and Cardiac Magnetic Resonance Imaging (2007) (12)
Enteroviral and Immune Mediated Myocarditis in SCID mice (2000) (12)
Utilization of telemedicine by heart disease patients following hospitalization (2008) (12)
Pacing-induced cardiomyopathy in chronic right ventricular apical pacing: a midterm follow-up study (2019) (12)
Brain natriuretic peptide as a predictor of cardiomyopathy in Chagas' disease (2003) (11)
The humoral immune response in viral heart disease: characterization and pathophysiological significance of antibodies (2004) (11)
Hemodynamic effects of vasorelaxant compounds in mice lacking one, two or all three angiotensin II receptors (2012) (11)
Intramyocardial Inflammation after COVID-19 Vaccination: An Endomyocardial Biopsy-Proven Case Series (2022) (11)
Reduced Cardiac Performance after Differential Pharmacological Stress in Streptozotocin-Induced Diabetic Rats (2010) (11)
Detection of parvovirus mRNAs as markers for viral activity in endomyocardial biopsy-based diagnosis of patients with unexplained heart failure (2020) (11)
Telbivudine Reduces Parvovirus B19-Induced Apoptosis in Circulating Angiogenic Cells (2019) (11)
Attenuation of left ventricular dysfunction by an ACE inhibitor after myocardial infarction in a kininogen-deficient rat model (2008) (11)
Complex porcine model of atherosclerosis: induction of early coronary lesions after long-term hyperlipidemia without sustained hyperglycemia. (2009) (10)
Randomized comparison of platelet-leukocyte aggregates and platelet activation in blood: heparin-coated coiled wire stent implantation versus balloon angioplasty in acute myocardial infarction. (2003) (10)
Lactate Dehydrogenase Isoenzyme Pattern in Myocardial Biopsies of Patients with Congestive Cardiomyopathy and with Alcoholic Cardiomyopathy — Clinical and Experimental Results (1980) (10)
The German Transregional Collaborative Research Centre ‘Inflammatory Cardiomyopathy – Molecular Pathogenesis and Therapy’ (2009) (10)
Case report of severe PCR-confirmed COVID-19 myocarditis in a European patient manifesting in mid January 2020 (2020) (10)
The cardiovascular influence of interleukin-1 beta on the expression of bradykinin B1 and B2 receptors. (2008) (10)
[PTCA in the acute state of myocardial infarct: hospital course of 785 consecutive patients]. (1994) (10)
Antibodies Against the Adenosine Di-/Triphosphate Carrier Cross-react with the Ca Channel — Functional and Biochemical Data (1988) (10)
High Perforin‐Positive Cardiac Cell Infiltration and Male Sex Predict Adverse Long‐Term Mortality in Patients With Inflammatory Cardiomyopathy (2017) (10)
Interferon- (cid:1) Treatment Eliminates Cardiotropic Viruses and Improves Left Ventricular Function in Patients With Myocardial Persistence of Viral Genomes and Left Ventricular Dysfunction (2003) (10)
[Mechanisms of extracellular matrix remodeling in dilated cardiomyopathy]. (2002) (10)
[Cardiac sarcoidosis: diagnostic validation by endomyocardial biopsy and therapy with corticosteroids]. (1997) (10)
[Detection of enteroviral RNA in endomyocardial biopsies in inflammatory cardiomyopathy and idiopathic dilated cardiomyopathy]. (1998) (10)
Does the C-Type Natriuretic Peptide Have Prognostic Value in Chagas Disease and Other Dilated Cardiomyopathies? (2006) (10)
Diagnosis and treatment of patients with virus induced inflammatory cardiomyopathy (2002) (9)
Inhibition of coagulation factor Xa improves myocardial function during CVB3-induced myocarditis. (2014) (9)
The impact of vessel and catheter position on the measurement accuracy in catheter-based quantitative coronary angiography (1998) (9)
[Myocarditis and dilated cardiomyopathy. New methods in diagnosis and therapy]. (2002) (9)
Myocardial lactate dehydrogenase patterns in volume or pressure overloaded left ventricles (2002) (9)
[Angina pectoris and ST-elevation after chemotherapy with 5-fluorouracil]. (2007) (9)
Antibodies Against Adenosine Di-/Triphosphate Carrier Alter Myocardial Function by Disturbing Cellular Energy Metabolism (1988) (9)
Transgenic Overexpression of Heart-specific Adenine Nucleotide Translocase 1 Positively Affects Contractile Function in Cardiomyocytes (2011) (9)
Cdc 2-Like Kinases and DNA Topoisomerase I Regulate Alternative Splicing of Tissue Factor in Human Endothelial Cells (2009) (9)
Accuracy and precision of the analytic calibration method in quantitative coronary arteriography (1996) (9)
Sodium-hydrogen exchange inhibition (1999) (9)
Human Parvovirus B19 (B19V) Up-regulates CXCR4 Surface Expression of Circulating Angiogenic Cells: Implications for Cardiac Ischemia in B19V Cardiomyopathy (2018) (9)
[18-year old patient with anti-epileptic therapy and sudden cardiac death]. (2003) (9)
Complete AV-block in two children with immunohistological proven myocarditis (1996) (8)
Adenine Nucleotide Translocase 1 Expression Is Coupled to the HSP27-Mediated TLR4 Signaling in Cardiomyocytes (2019) (8)
Why is diagnosis of infectious myocarditis such a challenge? (2011) (8)
Human thrombocytes are able to induce a myocardial dysfunction in the ischemic and reperfused guinea pig heart mediated by free radicals-role of the GPIIb/IIIa-blocker tirofiban. (2002) (8)
Classification of four chemically different amyloid types in routine endomyocardial biopsies by advanced immunohistochemistry (2011) (8)
Factors influencing the diagnostic accuracy of dobutamine stress echocardiography (1997) (8)
High-resolution respirometry in human endomyocardial biopsies shows reduced ventricular oxidative capacity related to heart failure (2019) (8)
Increased C reactive protein, cardiac troponin I and GLS are associated with myocardial inflammation in patients with non-ischemic heart failure (2021) (8)
Mitochondrial Function in Heart Failure (1999) (8)
Myocarditis—Personalized Medicine by Expanded Endomyocardial Biopsy Diagnostics (2014) (8)
[Non-surgical management of a perforated left anterior descending coronary artery following cardiopulmonary resuscitation]. (1999) (8)
Mesenchymal stem cells improve murine acute coxsackievirus B 3-induced myocarditis (2011) (8)
Doubling the clopidogrel dose in patients with reduced responsiveness to the standard dose is associated with a limited effectiveness as evaluated by impedance aggregometry. (2012) (7)
[Cardiac troponin T in the diagnosis and follow up of suspected myocarditis]. (1998) (7)
[Viral myocarditis: symptomatology, clinical diagnosis and hemodynamics]. (1984) (7)
Inhibition of platelet function with clopidogrel is associated with a reduction of inflammation in patients with peripheral artery disease. (2016) (7)
Structure and Regulation of the Murine Mash2 Gene (2003) (7)
[Viral myocarditis: symptomatology, clinical diagnosis and hemodynamics]. (1984) (7)
Cardiovascular Viral Infections (2010) (7)
Immunoelectrophoretic characterization of the ADP/ATP carrier from heart, kidney, and liver. (1985) (7)
[Surgical angioplasty of the left main coronary artery. Evaluation and postoperative follow-up with intravascular ultrasound]. (2002) (7)
Viral myocarditis. (2014) (7)
Impact of cell culture media on the expansion efficiency and T-cell receptor Vbeta (TRBV) repertoire of in vitro expanded T cells using feeder cells. (2008) (7)
Protease-Activated Receptor-2 Regulates the Innate Immune Response to Viral Infection in a Coxsackievirus B 3 – Induced Myocarditis (7)
[Cardiomyopathies. I: classification of cardiomyopathies--dilated cardiomyopathy]. (2005) (7)
CCR5del32 polymorphism is a protective factor in non-ischemic cardiomyopathy. (2014) (7)
Modulation of the acute defence reaction by eplerenone prevents cardiac disease progression in viral myocarditis (2020) (7)
Abciximab therapy is associated with increased platelet activation and decreased heparin dosage in patients with acute myocardial infarction (2005) (7)
The molecular basis of cardiotropic viral infections (2002) (7)
Excessive Hypertension and End-organ Damage in a Transgenic Mouse Line Carrying the Rat Angiotensinogen Gene (2009) (7)
Prognostic Significance of Circulating Levels of Hepatocyte Growth Factor in Patients with Chagas’ Disease and Idiopathic Dilated Cardiomyopathy (2012) (7)
Nf-kappab and AP-1 activation is associated with late lumen loss after porcine coronary angioplasty and antiproliferative beta-irradiation. (2007) (7)
[Contrast echocardiography for detection of incomplete rupture of the left ventricle after acute myocardial infarction]. (2004) (7)
Modulation of the isoform expression of Cyr61 and Integrin-αv in human microvascular endothelial cells (2013) (7)
LXR AGONISM IMPROVES TNF-ALPHA-INDUCED ENDOTHELIAL DYSFUNCTION (2013) (7)
Antibodies and Autoantibodies Against ADP/ATP Carrier Enhance Calcium Current in Isolated Ventricular Myocytes (1988) (7)
Phenotypic characterization of infiltrates in dilated cardiomyopathy - diagnostic significance of T-lymphocytes and macrophages in inflammatory cardiomyopathy. (2002) (7)
Neural cell adhesion molecule expression in dilated cardiomyopathy is associated with intramyocardial inflammation and hypertrophy. (2017) (6)
Nucleoside Analogue Reverse Transcriptase Inhibitors Improve Clinical Outcome in Transcriptional Active Human Parvovirus B19-Positive Patients (2021) (6)
Impairment of left ventricular function in combined immune deficiency mice after transfer of peripheral blood leukocytes from patients with myocarditis. (1995) (6)
Evaluation of Myocardial Gene Expression Profiling for Superior Diagnosis of Idiopathic Giant-Cell Myocarditis and Clinical Feasibility in a Large Cohort of Patients with Acute Cardiac Decompensation (2020) (6)
Does the Aminopeptidase A Have Prognostic and Diagnostic Value in Chagas Disease and Other Dilated Cardiomyopathies? (2011) (6)
[ Update 2001. Myocarditis--cardiomyopathy]. (2001) (6)
Recent Advances in Molecular Diagnostics and Treatment of Heart Muscle Diseases (2013) (6)
Inflammation and extracellular matrix protein metabolism: two sides of myocardial remodelling (2002) (6)
Vascular involvement in cardiac giant cell myocarditis: a new pathophysiological aspect (2014) (6)
[Short- and long-term effects of intensified versus conventional antilipidemic therapy in patients with coronary heart disease. Results from the Lipid-Coronary Artery Disease (L-CAD) Study]. (1999) (6)
Absent MicroRNAs in Different Tissues of Patients with Acquired Cardiomyopathy (2016) (6)
A detergent-induced charge shift as a prerequisite for the electrochemical analysis of the adenine nucleotide translocator, a basic membrane protein. (1984) (6)
[Diagnostic approach and optimal treatment of aortic valve stenosis]. (1998) (6)
[Diabetic cardiopathy: pathogenesis, diagnosis and therapy]. (2003) (6)
Mechanisms of late lumen loss after antiproliferative percutaneous coronary intervention using beta-irradiation in a porcine model of restenosis. (2007) (6)
Intra-individual head-to-head comparison of Sirolimus®- and Paclitaxel®-eluting stents for coronary revascularization. A randomized, multi-center trial. (2013) (5)
Coronary artery disease--diagnosis of ischaemia: general considerations. (1997) (5)
Missense Variant E1295K of Sodium Channel SCN5A Associated With Recurrent Ventricular Fibrillation and Myocardial Inflammation (2022) (5)
Ischaemia in patients with hypertrophic cardiomyopathy--various causes and symptoms and the difficulties of ischaemia screening tests. (1996) (5)
Genetic Deficiency in Neprilysin or Its Pharmacological Inhibition Initiate Excessive Stress-Induced Alcohol Consumption in Mice (2012) (5)
[Recurrent immune thrombocytopenia: a rare complication after contrast medium injection]. (1995) (5)
T1 and T2 mapping to detect chronic inflammation in cardiac magnetic resonance imaging in heart failure with reduced ejection fraction (2020) (5)
Sunday, 26 August 2012 (2012) (5)
Administration of regulatory T cells ameliorates myocardial inflammation in experimental myocarditis (2013) (5)
Prolonged clopidogrel application reduces tissue factor expression after percutaneous coronary intervention in the porcine model. (2011) (5)
Nicotinamide phosphoribosyltransferase/pre-B-cell colony enhancing factor/visfatin plasma levels and clinical outcome in patients with dilated cardiomyopathy. (2015) (5)
Magnetocardiographic mapping of QRS fragmentation in patients with a history of malignant tachyarrhythmias (2001) (5)
Beta Blockers Prevent Correlation of Plasma ACE2 Activity With Echocardiographic Parameters in Patients With Idiopathic Dilated Cardiomyopathy (2015) (5)
Scleral Inflammation around Collector Channels in Eyes with Primary Open-Angle Glaucoma (2020) (5)
Immunosuppressive treatment in fulminant myocarditis and gene expression pattern associated with, but no histological confirmation of giant cell myocarditis (2017) (5)
Dose-related effects of ACE inhibition in man: quinapril in patients with moderate congestive heart failure. The Study Group on Neurohormonal Regulation in Congestive Heart Failure: Lausanne, Switzerland; Berlin, Düsseldorf, Munich, Germany. (1994) (5)
[Pathogenesis of inflammatory cardiomyopathies]. (1998) (4)
Transcriptional Active Parvovirus B19 Infection Predicts Adverse Long-Term Outcome in Patients with Non-Ischemic Cardiomyopathy (2021) (4)
[Increased thrombocyte activation in dilated cardiomyopathy: a risk factor for development of ventricular thrombosis despite anticoagulant therapy?]. (2002) (4)
Polymorphonuclear granulocytes induce myocardial dysfunction during ischemia and in later reperfusion of hearts exposed to low‐flow ischemia (2001) (4)
Mononuclear cell secretome in autoimmune myocarditis. (2015) (4)
LONG TERM RISK OF DEATH, TRANSPLANTATION AND DISEASE RECURRENCE IN GIANT CELL MYOCARDITIS (2012) (4)
Amino-terminal Fragment of C-type Natriuretic Peptide Precursor and C-type Natriuretic Peptide Do Not Correlate in Patients With Chagas Disease: Role For Neutral Endopeptidase (2010) (4)
Ventricular tachycardia indicating cardiac involvement in metastatic leiomyosarcoma. (2006) (4)
Images in clinical medicine. Embolization of the tip of a central venous catheter into the pulmonary artery. (2005) (4)
[Immunosuppressive therapy in myocarditis and dilated cardiomyopathy?]. (1992) (4)
Giant cell myocarditis after first dose of BNT162b2 – a case report (2022) (4)
[Antiviral therapy in viral heart disease]. (2004) (4)
Chronic viral and inflammatory cardiomyopathy (2006) (3)
Shocks after implantable cardioverter-defibrillator implantation in idiopathic cardiomyopathy patients: a myocardial biopsy study (2018) (3)
Leukocyte CD15 Expression and Platelet Activation in the Coronary Sinus after Coronary Intervention (2003) (3)
Images in cardiovascular medicine. Parvovirus-B19-associated active myocarditis with biventricular thrombi. Results of endomyocardial biopsy investigations and cardiac magnetic resonance imaging. (2007) (3)
The Significance of T Cell Responses in Human Myocarditis (1997) (3)
Acute and chronic effects of nitrendipine on hemodynamics and myocardial ischemia in patients with combined angina pectoris and hypertension. (1988) (3)
[Magnetcardiographic detection of abnormal intraventricular activation in patients with ischemic heart disease with and without tachycardia]. (1997) (3)
First-line treatment of hypertension: critical appraisal of potential role of aliskiren and hydrochlorothiazide in a fixed combination (2010) (3)
Monday, 27 August 2012 (2012) (3)
Viruses and other environmental factors as possible sources of phenotypic heterogeneity in familial dilated cardiomyopathy. (2006) (3)
Mitochondrial haplogroups and expression studies of commonly used human cell lines. (2016) (3)
Interferon-β Suppresses Transcriptionally Active Parvovirus B19 Infection in Viral Cardiomyopathy: A Subgroup Analysis of the BICC-Trial (2022) (3)
Enoxaparin injection for the treatment of high-risk patients with non-ST elevation acute coronary syndrome (2007) (3)
Recent Advances in Molecular Diagnostics and Treatment of Heart Muscle Diseases —From Biopsy-Focused to Systemic Diagnostics (2013) (3)
Multimodality Imaging Reveals Divergent Responses of Left and Right Heart to Treatment in Cardiac Amyloidosis (2019) (3)
Old age and chronic disease: is the emergency medical system the appropriate provider for the elderly? (2014) (3)
Human Coxsackie-Adenovirus Receptor Is Colocalized With Integrins &agr;v&bgr;3 and &agr;v&bgr;5 on the Cardiomyocyte Sarcolemma and Upregulated in Dilated Cardiomyopathy: Implications for Cardiotropic Viral Infections (2001) (3)
[Potential embolism sources in transesophageal echocardiography--prognostic value in patients with cerebral ischemia]. (1996) (3)
Exposure to Type 2 Diabetes Provokes Mitochondrial Impairment in Apparently Healthy Human Hearts (2020) (3)
Foreshortening display: an on-line method for spatial interpretation and projection assessment of the target coronary segment (1998) (3)
[Cardiomyopathies II. Hypertrophic cardiomyopathy, restrictive cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy]. (2005) (3)
Adenine nucleotide translocase 1 expression affects enterovirus infection in human and murine hearts. (2014) (3)
[Development and validation of a graphic method for spatial interpretation and evaluation of biplanar coronary angiograms]. (1999) (2)
ANALYSIS OF ENDOMYOCARDIAL BIOPSIES IN CARDIOMYOPATHIES: DIAGNOSTIC VALUE ON LEFT VERSUS RIGHT VENTRICULAR BIOPSY (2014) (2)
Cardiomyopathies - The special entity of myocarditis and inflammatory cardiomyopathy (2019) (2)
[Is Na+Ca(2+) exchanger expression altered in the endomyocardium of patients with chronic heart valve diseases parallel to myocardial dysfunction?]. (2000) (2)
Measurement of multiple cytokines for discrimination and risk stratification in patients with Chagas’ disease and idiopathic dilated cardiomyopathy (2021) (2)
[Optimal management of primary and secondary mitral regurgitation]. (1998) (2)
New Therapeutics Targets in Chronic Viral Cardiomyopathy (2006) (2)
Fulminant parvovirus B19 myocarditis after chemotherapy: full recovery after antiviral therapy with tenofovir (2021) (2)
[Immunosuppressive therapy for effective suppression of life threatening ventricular tachyarrhythmias in chronic myocarditis]. (1997) (2)
Reversible transition from a hypertrophic to a dilated cardiomyopathy (2015) (2)
Myocarditis: treatment of myocarditis (2018) (2)
What are the current treatment options for myocarditis (2009) (2)
Myocardial lactate dehydrogenase isoenzyme distribution in the normal heart (1981) (2)
Adenosine stress perfusion cardiac magnetic resonance imaging in patients undergoing intracoronary bone marrow cell transfer after ST-elevation myocardial infarction: the BOOST-2 perfusion substudy (2019) (2)
Antibodies Against the ADP/ATP Carrier Interact with the Calcium Channel and Induce Cytotoxicity by Enhancement of Calcium Permeability (1988) (2)
Immunohistochemical Analysis of Inflammatory Heart Disease (1997) (2)
The impact of lesion location on the accuracy of catheter calibrated vessel dimensions in routine quantitative coronary arteriography (1995) (2)
[Acute hantavirus infection caused by a genetically newly identified viral strain. Severe and complicated course of hemorrhagic fever with renal syndrome (nephropathia epidemica)]. (1999) (2)
[Possible errors in diagnosis of left atrial thrombosis in transesophageal echocardiography]. (1996) (2)
295 Staged telemedical service for patients with mild‐to‐moderate congestive heart failure (2007) (2)
Inflammatory cardiomyopathy (DCMi) : pathogenesis and therapy (2010) (2)
Human myocardial mitochondrial oxidative capacity is impaired in mild acute heart transplant rejection (2021) (2)
[Antimyosin scintigraphy for diagnosis and follow-up of patients with clinically suspected myocarditis]. (1998) (2)
Role of Monokine Induced by Interferon Gamma in Discrimination and Prognosis of Patients With Chagas' Disease and Idiopathic Dilated Cardiomyopathy (2016) (2)
799-3 Left Ventricular Function and Immunohistological Findings in Patients with Dilated Cardiomyopathy: A Follow-up Study (1995) (1)
Parvovirus B19 NS1 and VP1/2 mRNAs expression indicates viral activity in endomyocardial biopsy-based diagnosis of patients with unexplained heart failure (2020) (1)
Correlation of Antimyosin-Scintigraphy With Histological and Immunohistological Findings in the Endomyocardial Biopsy in Patients With Clinically Suspected Myocarditis (1998) (1)
Quantitative coronary arteriography: improving catheter calibration by an efficient correction for differential magnification (1995) (1)
The effects of chronic ethanol treatment on oligomycin sensitive ATPase activity in the guinea pig heart (1985) (1)
Response to Letter Regarding Article, “Role of Left Ventricular Stiffness in Heart Failure With Normal Ejection Fraction” (2009) (1)
[Biphasic course of left ventricular dysfunction in a 22-year-old female with acute myocarditis]. (2008) (1)
Anti-viral treatment in patients with virus-induced cardiomyopathy. (2006) (1)
Advanced diagnostics in inflammatory cardiomyopathy for personalized therapeutic decision-making. (2022) (1)
The Adenine Nucleotide Translocator: A Major Autoantigen in Myocarditis and Dilated Cardiomyopathy (1997) (1)
[Diagnostic advantage by transthoracic and transesophageal echocardiography in acute ischemic infarct. A contribution to indications for transesophageal echocardiography]. (1996) (1)
[Syncope in 3rd degree atrioventricular block. Detection of virus genome in the myocardium]. (1998) (1)
308Cardiac fibroblasts as inflammatory supporter cells trigger cardiac inflammation in heart failure (2014) (1)
102 Immunohistological detection of parvovirus B19 VP1‐ and VP2‐capsid proteins in endomyocardial biopsies from dilated cardiomyopathy patients (2007) (1)
after Myocardial Infarction in Mice Induction of Left Ventricular Remodeling Toll-Like Receptor-4 Modulates Survival by (2013) (1)
Global plasma protein profiling reveals DCM characteristic protein signatures. (2019) (1)
Validation of online cardiac 3-D localization using isocenter-based biplane radiography and instrumental rotational image alignment (1998) (1)
ADIPONECTIN INHIBITS TOLL-LIKE RECEPTOR 4 MEDIATED CARDIAC INFLAMMATION AND INJURY (2012) (1)
Abstract 5881: Influence Of Cardiac Inflammation And Extracellular Matrix Regulation On Diastolic Dysfunction In Patients With Heart Failure With Normal Ejection Fraction (2008) (1)
FOXO3a regulates viral load and inflammation in acute Coxsackievirus B3 myocarditis - role of NK cell function (2013) (1)
Abstract 1103: Integrin-linked Kinase and Laminin alpha 4 Mutations Cause Human Cardiomyopathy (2007) (1)
Non-invasive recording of the arrhythmogenic substrate within the QRS-complex using magnetocardiography (1996) (1)
Cardiomyopathy: a post-viral autoimmune disease? (1992) (1)
[Differentiation between vital heart muscle tissue and infarct scar using magnetocardiography]. (2002) (1)
Influence of angiotensin-(1-7)-receptor agonist AVE0991 on heart rate and blood pressure variability and baroreceptor sensitivity (2004) (1)
[3-D localization of cardiac structures in real time]. (2000) (1)
Renin-Angiotensin System Vascular-Protective Effects of High-Density Lipoprotein Include the Downregulation of the Angiotensin II Type 1 Receptor (2009) (1)
Modulation of inflammation and MMP2 activity by IL4-treatment in a CVB-3 induced chronic myocarditis model in SWR/J-mice (2005) (1)
FOXO3A DEPENDENT ADIPONECTIN EXPRESSION – IMPLICATIONS FOR MYOCARDIAL INFLAMMATION (2012) (1)
Effect of Angiotensin-Converting Enzyme Inhibitors on Energy Metabolism in Chronic Heart Failure - Enzymatic Studies of Myocardial Biopsies (1988) (1)
Increased high density lipoprotein cholesterol induced by human apolipoprotein A-1 gene transfer increases adiponectin expression in abdominal adipose tissue (2007) (1)
[Chest pain, reduced physical activity, and polyserositis in a 35-year old patient with anticonvulsive medication]. (2006) (1)
QUANTITATIVE IMMUNOELECTROPHORESIS FOR COMPARATIVE ANALYSIS OF HYDROPHOBIC INTRINSIC MEMBRANE PROTEINS (1983) (1)
Abstract 3807: Chronic Cardiac-Targeted RNA Interference for the Treatment of Severe Heart Failure Restores Cardiac Function and Reduces Pathological Hypertrophy (2008) (1)
Rational of the use of aliskiren in hypertension and beyond. (2009) (1)
Tuesday, 28 August 2012 (2012) (1)
P6033Impaired myocardial mitochondrial function correlates with inflammatory cell burden in humans following heart transplantation (2017) (1)
CARDIAC INVOLVEMENT OF HUMAN HERPESVIRUS 6 IN PATIENTS WITH INFLAMMATORY CARDIOMYOPATHY (2015) (1)
Diagnostic endomyocardial biopsy interpretation. (2003) (1)
[Acute coronary artery occlusion after elective percutaneous transluminal coronary angioplasty. Incidence and therapy in 5000 consecutive patients]. (1994) (1)
Development and clinical evaluation of an online procedure for lesion length measurement in coronary intervention (1999) (1)
Abstract 13892: Therapeutic Suppression of Parvovirus B19 Replication with the Thymidine Analog Telbivudine Improves Clinical Outcome in Chronic Myocarditis and Reduces Apoptosis in Circulating Angiogenic Cells (2012) (1)
[Genetic testing is superior to biopsy of the myocardium in cardiomyopathy - no]. (2013) (1)
Immunohistological diagnosis of inflammatory cardiomyopathy and diagnosis of cardiotropic viral infections (2010) (1)
Adiponectin attenuates adverse cardiac remodeling in inflammatory heart disease by induction of matrix metalloproteinase-9 expression (2013) (0)
P4532High cytotoxic cells infiltration and male gender predict adverse long-term mortality in patients with inflammatory cardiomyopathy (CMi) (2018) (0)
Struktur und Regulation des murinen Mash2-Gens (2003) (0)
[Mechanism of induction and termination of ventricular fibrillation--significance of dispersion of ventricular repolarization]. (2000) (0)
Contents, Vol. 128, 1949 (1949) (0)
Entwicklung und Validierung eines graphischen Verfahrens zur räumlichen Interpretation und Bewertung biplaner Koronarangiogramme - Development and Validation of a Graphic Method for the Spatial Interpretation and Assessment of Biplane Coronary Angiograms (1999) (0)
Use of microRNAs or genes as markers to identify, diagnosis and therapy of individual non-ischemic cardiomyopathy or storage diseases of the heart (2012) (0)
Aliskiren-Hydrochlorothiazide in Combination: Efficacy Review in Mild to Moderate Hypertension (2010) (0)
242 Pressure-volume loop analysis shows a strong correlation between NT-proBNP and left ventricular stiffness in patients with isolated diastolic dysfunction (2005) (0)
783 Reduction of HMG-CoA-reductase leads to improved cardiac function in doxorubicin-induced cardiomyopathy in mice (2008) (0)
Regulation of alternative splicing of the Tissue factor gene in TNF-alpha stimulated human endothelial cells (2007) (0)
[Acute viral myocarditis. 1: Pathogenesis, clinical manifestations, diagnosis]. (1991) (0)
Poster session 3 (2001) (0)
FOXO3A DEFICIENCY PROTECTS FROM COXSACKIEVIRUS B3 MYOCARDITIS: ROLE OF NK CELL FUNCTION (2015) (0)
278 Profile of the anti‐Parvovirus B19 humoral response in patients with clinically suspected acute myocarditis, chronic myocarditis and dilated cardiomyopathy (2006) (0)
[Quantifying stenosis and evaluating projection--an online realization in the catheter laboratory]. (2009) (0)
Subject Index Vol. 110, 2008 (2007) (0)
Immunosuppressive treatment in familial dilated cardiomyopathy with biopsy-proven intramyocardial inflammation? (2003) (0)
Abstract 15471: Prognostic Value of Cytotoxic T Lymphocytes in Endomyocardial Biopsies of Patients with Dilated Inflammatory Cardiomyopathy (2012) (0)
Impaired Myocardial Mitochondrial Respiration in Humans With Prediabetes: A Footprint of Prediabetic Cardiomyopathy. (2022) (0)
CCR5del32 genotype in human enteroviral cardiomyopathy leads to spontaneous virus clearance and improved outcome compared to wildtype CCR5 (2018) (0)
Abstract 805: Differential Regulation Of Cytokine-induced Alternative Splicing Of The TF Gene By Serine/Arginine Rich Protein Kinases (2007) (0)
The need of personalized medicine and specific treatment in inflammatory cardiomyopathy to improve prognosis (2016) (0)
49 Toll‐like receptor 4 deficiency reduces LV remodelling and mortality rate after myocardial infarction in mice (2007) (0)
Erratum to: Selective PDE5A inhibition with sildenafil rescues left ventricular dysfunction, inflammatory immune response and cardiac remodeling in angiotensin II-induced heart failure in vivo (2013) (0)
1144-132 L-type calcium channel inhibitor diltiazem prevents diastolic dysfunction and stress-induced cardiac decompensation and death in a mouse model of familial hypertrophic cardiomyopathy (2004) (0)
G-Protein–Coupled Receptor Mas Is a Physiological Antagonist of the Angiotensin II Type 1 Receptor Molecular Cardiology (2005) (0)
Proteins of the sarcoplasmic reticulum as potential targets for gene therapy of heart failure (2000) (0)
Interleukin 23 deficiency leads to increased myocardial inflammation and impaired wound healing after experimental myocardial infarction by controling the function of cardiac fibroblasts (2013) (0)
Rapamycin and paclitaxel increase the expression and activity of tissue factor in human aortic smooth-muscle cells (2007) (0)
INTERLEUKIN 23 REDUCES MYOCARDIAL INFLAMMATION AND IMPROVES INFARCT HEALING AFTER EXPERIMENTAL MYOCARDIAL INFARCTION BY CONTROLING THE FUNCTION OF CARDIAC FIBROBLASTS (2013) (0)
Inflammatory cardiomyopathy (DCMi) (2010) (0)
Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic (2007) (0)
1164-128 Endothelial function of the coronary microcirculation is impaired in patients with myocardial virus persistence (2004) (0)
How many parameters are really needed for the analysis of heart rate variability (1996) (0)
Moderated Poster Session 3 (2012) (0)
CCR5DEL32 GENOTYPE AS A PREDICTIVE MARKER FOR HUMAN ENTEROVIRAL CARDIOMYOPATHY (2016) (0)
104 Reduction of the cardiac inflammatory response after interleukin 1β-converting-enzyme-inhibition improves left ventricular function in experimental diabetic cardiopathy (2003) (0)
[Progress in therapy of heart failure. Mortality halved]. (2003) (0)
3-D-Lokalisation kardialer Strukturen in Echtzeit - Real Time 3-D Localisation of Cardiac Structures (2000) (0)
Abstract 1471: Vascular-protective Effects of High Density Lipoprotein Include the Down-regulation of the AT1 Receptor (2006) (0)
Coxsackie-adenovirus-receptor induction is associated with enteroviral and adenoviral infection in acute myocarditis and dilated cardiomyopathy (2003) (0)
P1328High-Resolution Respirometry in Human Endomyocardial Biopsies to Assess Myocardial Mitochondrial Function (2017) (0)
118 Increased cardiac CXCR4+/cKit+ cell density in patients with angina and cardiac Parvovirus B19 persistence (2008) (0)
The cardioprotective role of PAI-1 in human inflammatory cardiomyopathy (2022) (0)
153 Coxsackie‐adenovirus‐receptor induction is associated with enteroviral and adenoviral infection in acute myocarditis and dilated cardiomyopathy (2003) (0)
Global longitudinal 2D strain for evaluation of myocarditis as proven by endomyocardial biopsy (2013) (0)
48 Eplerenone treatment in a CVB‐3 induced myocarditis model reduces cardiac fibrosis resulting in an improved left ventricular function (2007) (0)
, Dirk Adults With ' ' Idiopathic ' ' Left Ventricular Dysfunction High Prevalence of Viral Genomes and Multiple Viral Infections in the Myocardium of (2005) (0)
O-69 Prehospital thrombolysis after cardiopulmonary resuscitation: A high risk procedure? (1996) (0)
Fragmentation of Signals Within the QRS-Complex Detected by Magnetocardiography (1998) (0)
Abstract 17775: Foxo3a Regulates Response to Coxsackievirus B3 Myocarditis via microRNA-155 Triggered NK-cell Activity (2014) (0)
Is out-of-hospital sudden cardiac death an unexpected event? (1996) (0)
44 Beneficial effects of pharmacological enhancement of the endothelial NO synthases on cardiac function and hypertrophy in an animal model of heart failure despite normal EF (2007) (0)
JS4-2 Diagnosis and Treatment of Chronic Viral Cardiomyopathy (CVC) (2009) (0)
[Foreshortened imaging: a new method for spatial interpretation and evaluating the view of the coronary region of interest]. (2009) (0)
FOXO3A MODULATES CARDIAC REMODELING VIA INHIBITION OF MYOFIBROBLAST DIFFERENTIATION IN ACUTE MYOCARDIAL INFARCTION (2015) (0)
P6270The Protease-Activated Receptors 1 and 2 mediate heart failure with preserved ejection fraction (HFpEF) and cardiac fibrosis (2017) (0)
Poster session V * Saturday 11 December 2010, 08:30-12:30 (2010) (0)
Changes in cardiac repolarization caused by interferon therapy (2001) (0)
406 Accelerated mitochondrial ATP supply prevents cardiac failure (2006) (0)
P4220Mild cellular heart transplant rejection is associated with decreased myocardial mitochondrial respiration and coupling efficiency (2018) (0)
FOXO3A DEFICIENCY AND VIRAL LOAD IN ACUTE COXSACKIEVIRUS B3 MYOCARDITIS: ROLE OF NK CELL FUNCTION (2013) (0)
536 TIR‐domain‐containing adaptor protein inducing IFN‐beta (TRIF) is essential in coxsackievirus B3‐indused myocarditis in mice (2008) (0)
The Significance of Autoantibodies and the Role of the ADP/ATP Carrier in the Pathogenesis of Viral Heart Disease, Myocarditis and Dilated Cardiomyopathy (1993) (0)
Abstract 20640: Human Parvovirus B19 Induces Apoptosis Through the Nonstructural Proteins NS1 and 11kDa in Circulating Cells With Endothelial Regenerative Potential (2010) (0)
[Significance of silent myocardial ischemia for identification and optimal therapy of patients with latent coronary heart disease. Is there a marker for prognostic indication for PTCA?]. (1999) (0)
Drugs and/or devices in dilated cardiomyopathy (2010) (0)
Angiotensin II regulates renal C-type natriuretic peptide in diabetes mellitus (2000) (0)
First clinical experience with the new generation cryoballoon technology: acute procedural and long term results (2013) (0)
Myocardial energy supply in heart failure (1992) (0)
Antiviral interferon-β treatment in patients with chronic viral cardiomyopathy (2010) (0)
Verbesserung der Diabetes-mellitus-bedingten Endothelfunktion nach Inhibition der p38-MAP-Kinase (2003) (0)
41The cardiac protease-activated receptor 2 expression is crucial for the maintenance of the cardiac function in the aged heart (2014) (0)
[Quality analysis for treatment of heart muscle diseases]. (2009) (0)
FOXO3A acts as immune response modulator in human virus-negative inflammatory cardiomyopathy (2023) (0)
Wall motion analysis of stress echocardiography: Eyeball vs. Trackball interpretation (1995) (0)
Sunday, 18 July 2010 (2010) (0)
[Cardioprotection by means of Candesartan in cardiac insufficiency. CHARM overall partial evaluation (Candesartan in heart failure assessment of reduction in mortality and morbidity)]. (2006) (0)
High density lipoprotein cholesterol improves left ventricular function in obese rats via upregulation of adiponectin receptors and activation of AMP-activated protein kinase (2006) (0)
783 Angiotensinogen overexpression as an inductor of myocardial inflammation in mice (2005) (0)
540 Paradox effects of MMP‐2 and MMP‐9 are beneficial in viral induced experimental myocarditis (2008) (0)
449 The bradykinin B1 receptor contributes to the cardio-protective effects of AT1 blockade after experimental myocardial infarction (2003) (0)
Brazilian Society of Cardiology Guideline on Myocarditis - 2022. (2022) (0)
Intramyocardial inflammation in dilated cardiomyopathy--what makes a difference? (2002) (0)
Autonomic nervous dysfunction in patients with implanted defibrillator (1996) (0)
87-OR: NF Kappa B Expression Is Related to Diabetes and Impaired Respiratory Capacity of Human Ventricular Myocardium (2020) (0)
Abstract 9884: Cardiac Iron Concentration in Relation to Systemic Iron Status and Disease Severity in Dilated Cardiomyopathy (2019) (0)
Increased C reactive protein, cardiac troponin I and GLS are associated with myocardial inflammation in patients with non-ischemic heart failure (2021) (0)
Angiotensin-(1-7) stimulates bone marrow-derived progenitor cells in vitro and in vivo, leading to cardioprotection after myocardial infarction in rodents (2008) (0)
716 P38 MAP kinase inhibition attenuates left ventricular dysfunction by down regulating of pro‐inflammatory cardiac cytokines in an animal model of diabetes mellitus (2006) (0)
Cardio-protective myocardial inflammation in myocarditis (1999) (0)
Abstract 3811: Inhibition of Coxsackievirus B3-Induced Myocarditis by Adenovector-Mediated Doxycycline (Dox)-Dependent Expression of a Soluble Coxsackie- and Adenovirus-Receptor (2008) (0)
Cardiomyopathy Impair Cardiac Function (2005) (0)
834-2 Clonal T-cell composition is not associated with enteroviral or adenoviral infection in dilated cardiomyopathy: Implications for the pathogenesis of dilated cardiomyopathy (2004) (0)
Abstract 21671: Diastolic Dysfunction Triggers Chemotactic Activity and Accumulation of Extracellular Matrix by Activating Myofibroblasts in Patients With Heart Failure and Normal Ejection Fraction. An in vivo and in vitro Approach. (2010) (0)
Dispersion of the repolarization can be quantified by magnetocardiographic mapping in patients with malignant tachyarrhythmias (1996) (0)
243 Primary pulmonary artery hypertension induces left ventricular diastolic dysfunction (2005) (0)
243 N‐Terminal pro‐B Type Natriuretic Peptide serves as a rapid and reliable plasma biomarker for detecting isolated diastolic dysfunction (2004) (0)
Does myocardial viability detected by low-dose dobutamine stress echocardiography identify patients following acute myocardial infarction who's left ventricular regional function recovers after revascularization? (1995) (0)
Seasonal and weekly variations in risk of sudden death (1996) (0)
MMP13 prevents cardiac injury and left ventricular dysfunction in Coxsackievirus B3-induced acute myocarditis (2013) (0)
527 Cardiomyocyte‐restricted overexpression of C‐type natriuretic peptide improves cardiac remodeling after myocardial infarction in mice (2006) (0)
Role of impaired myocardial relaxation in the production of elevated left ventricular filling pressure (2005) (0)
510 Enhancement of eNOS leads to an improvement of endothelial function in experimental diabetes mellitus (2005) (0)
P618PAR2 expression differentially regulates immune response upon treatment with Poly(I:C) and LPS (2014) (0)
P2574A 10 years observation study in patients with virus-negative inflammatory cardiomyopathy after immunosuppressive treatment (2017) (0)
[Accuracy and precision of analytical calibration in quantitative coronary angiography]. (1997) (0)
Erratum to: A distinct subgroup of cardiomyopathy patients characterized by transcriptionally active cardiotropic erythrovirus and altered cardiac gene expression (2013) (0)
Chapter 2 Angiotensin ( 1-7 ) stimulates bone marrow-derived progenitor cells in vitro and in vivo (2017) (0)
Abstract 17995: Inhibition of Myofibroblast Differentiation by FOXO3a - Implications for Acute Myocardial Infarction and Cardiac Remodeling (2014) (0)
Abstract 19779: Nod2 Knock Down Improves Left Ventricular Function and Attenuates Pathophysiological Key Mechanisms in Experimental Coxsackievirus B3-induced Myocarditis (2015) (0)
718 Dominance of T‐cell‐receptor Vbeta (TRBV) 7, 9, 20 and 30 in endomyocardial biopsies from patients with Parvovirus B19 associated acute myocarditis (2007) (0)
70 Increased left ventricular dilatation and mortality in biglycane knock out mice after induction of myocardial infarction (2005) (0)
Abstract 5633: Endothelial Progenitor Cells - A Troian Horse in Systemic Endothelial Damage in Patients With Cardiac Parvovirus B19? (2009) (0)
Transgenic overexpression of adenine nucleotide translocase 1 protects ischemic hearts against oxidative stress (2016) (0)
721 Meta‐analysis on the immunohistological and histological proof of intramyocardial inflammation in myocarditis and dilated cardiomyopathy (2007) (0)
[Pericardial effusions, cardiac tamponade, armored heart. Preventing sequelae of pericarditis]. (2002) (0)
Prevalence and outcome of cardiac amyloidosis in an all-comer population of patients with non-ischaemic heart failure (2021) (0)
[Endomyocardial biopsy in cardiomyopathy: when and why?]. (2009) (0)
Efficacy of the first countershock in prolonged ventricular fibrillation (1996) (0)
LOCAL INTRACORONARY ROSIGLITAZONE TREATMENT INDUCES A VASOPROTECTIVE GENE EXPRESSION PROFILE AND COMPLETE REENDOTHELIALIZATION IN A PORCINE IN STENT-RESTENOSIS MODEL (2010) (0)
New aspects in inflammatory cardiomyopathy — diagnosis and therapy (2002) (0)
Diagnostics of mitochondrial DNA mutations associated with cardiomyopathies (2013) (0)
Autoimmunity in Cardiomyopathies (2003) (0)
INFLAMMATION INDUCES TRANSDIFFERENTIATION OF FIBROBLASTS TO MYOFIBROBLASTS WITH PATHOLOGICAL REMODELLING IN ENDOMYOCARDIAL BIOPSIES OF PATIENTS WITH HFNEF: ONE TRIGGER FOR DIASTOLIC DYSFUNCTION. (2010) (0)
Centre of Excellence: Charité Centre for Cardiovascular Medicine, Universitätsmedizin Berlin, Berlin, Germany Showing Thatovel Therapies Aimed at Virus Elimination Are Beneficial in Certain Cardiomyopathies (2009) (0)
Abstract 15187: The Nonstructural Proteins Ns1 and 11kda of Human Parvovirus B19 Induce Apoptosis Through Caspases 8 and 10 Inducing Dysfunction of Circulating Cells with Endothelial Regenerative Potential (2011) (0)
77 C‐type natriuretic peptide regulation in Chagas disease and other dilated cardiomyopathies (2007) (0)
Poster Session 3 (2012) (0)
Abstract 978: Novel Endothelial-protective Effect of High Density Lipoprotein: Down-regulation of Toll-like Receptor 4 (2007) (0)
[Immunosuppressive therapy in myocarditis and dilated cardiomyopathy--a critical analysis]. (1989) (0)
[Effect of angiographic projection of blood vessel and calibration catheter on accuracy of quantitative coronary angiography]. (1997) (0)
QUANTUM TECHNOLOGIES IN THE HELMHOLTZ ASSOCIATION (2019) (0)
[Acute infectious endocarditis]. (1997) (0)
Measurement of the regional exposure quality in quantitative coronary angiography (2000) (0)
European (jß Volume 12 Supplement D Pages 1-205 Pericardioscopy—a New Diagnostic Tool in Inflammatory Diseases of the Pericardium the Role of Pericardiectomy in Pericardial Disorders the Value of Endomyocardial Biopsies in Myocarditis and Dilated Cardiomyopathy Endomyocardial Biopsy Findings in Case (0)
Contents Vol. 110, 2008 (2007) (0)
Abstract 994: Alternative Splicing of Tissue Factor is Mediated by Clks in Human Endothelial Cells Stimulated with TNF-Alpha (2006) (0)
Inflammatory Cardiomyopathy: Diagnostic and Therapeutical Options (1998) (0)
806-4 Cardiac parvovirus type B19 infection is associated with isolated diastolic dysfunction (2004) (0)
Changing of cardiac repolarization pattern in response to thoracic electrical shock application (2008) (0)
[Supporting primary stent implantation by angiographic length measurement]. (2002) (0)
Abstract 1947: Interferon-beta Treatment Improves Parvovirus B19-induced Vascular Damage And Normalises Numbers Of CD34+ KDR+-Progenitors In Patients With Parvovirus B19 Positive positive inflammatory cardiomyopthy (2007) (0)
[Modern aspects in the management of acquired heart valve lesions]. (1998) (0)
Cardiovascular characterization of mice deficient in all three angiotensin II receptors (2007) (0)
CardiomyopathyTRIF Is a Critical Survival Factor in Viral (2011) (0)
[Etiopathogenetic differentiation of inflammatory cardiomyopathy. Immunosuppression and immunomodulation]. (1997) (0)
Use of circulating in the blood serum or blood plasma microRNAs for identification of patients requiring biopsy and as a marker for the differential diagnosis of individual non-ischemic cardiomyopathy or storage diseases of the heart (2015) (0)
[Acute viral myocarditis. 2: Therapy]. (1991) (0)
Abstract 17628: Perforin-positive Cardiac Cell Infiltration and Male Gender Predict Adverse Long-term Mortality in Virus-negative Inflammatory Cardiomyopathy (2016) (0)
TCT-494 Renal sympathetic denervation reduces blood pressure in patients with less distinct resistant hypertension (2013) (0)
Novel endothelial-protective effect of high density lipoprotein: Down-regulation of toll-like receptor 4 (2007) (0)
Abstract 2188: Imbalance In The Mmp timp-system And Myocardial Fibrosis In Patients With Inflammatory Cardiomyopathy (2007) (0)
Abstract 5901: Cardiac Expression of CCN1, Capable of Promoting Adhesion of CD34+ Progenitor Cells, Is Strongly Induced in Parvovirus B19-Associated Cardiomyopathy (2008) (0)
[In focus: Inflammatory cardiomyopathy]. (2006) (0)
Ventricular endomyocardial mitochondrial impairment and inflammation accompany diastolic dysfunction in the type 2 diabetic human heart (2020) (0)
98 Anti‐inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy (2005) (0)
[Beta blockers in post-infarction state]. (2002) (0)
Deteriorated contractility and disturbance of the myocardial energy metabolism in A.CA/SNJ mice following immunisation with the ADP/ATP carrier (1991) (0)
Three-D localization of the coronary segment and calibration catheter to correct for differential magnification in quantitative coronary angiography (1999) (0)
Abstract 18172: FOXO3a Controls Viral Load in Acute Coxsackievirus B3 Myocarditis - Role of NK Cell Function (2012) (0)
Angiotensin (1-7) stimulates bone marrow-derived progenitor cells in vitro and in vivo (2008) (0)
THE DEFICIENCY OF PROTEASE-ACTIVATED RECEPTOR 2 LEADS TO AN AGE DEPENDENT CARDIAC FIBROSIS AND LEFT VENTRICULAR DIASTOLIC DYSFUNCTION (2014) (0)
Contents Vol. 121, 2012 (2012) (0)
[Consensus conference "Therapy of chronic heart insufficiency" inaugurated by the Munich Collegium for Therapy Research e.V. together with the German Society for Cardiovascular Research]. (1993) (0)
Abstract 17890: High Perforin-Positive Cardiac Cell Infiltration and Male Gender Predict Adverse Long-Term Mortality in Patients With Inflammatory Cardiomyopathy (2017) (0)
PERFORIN-POSITIVE CARDIAC CELL INFILTRATION AND MALE GENDER PREDICT ADVERSE LONG-TERM MORTALITY IN INFLAMMATORY CARDIOMYOPATHY (2016) (0)
156 Clonal T-cell composition, detected by analysis of the T-cell receptor beta chain, is exclusively present in dilated cardiomyopathy, and not associated with enteroviral or adenoviral infection (2003) (0)
P6450Plasminogen activator inhibitor type-1 (PAI-1) expression relates to the presence of myocardial inflammation in patients with nonischemic cardiomyopathy (2019) (0)
1013-114 Improvement of endothelial function in patients with myocardial inflammation by angiotensin-converting enzyme inhibition with quinapril: A randomized double-blind, placebo controlled study (2004) (0)
Adenine Nucleotide Translocase 1 Expression Modulates the Immune Response in Ischemic Hearts (2021) (0)
Abstract 18205: FOXO3a regulates Myofibroblast Differentiation - Implications for Cardiac Remodeling (2012) (0)
Abstract 161: Cardiomyocytes Release Tissue Factor-positive Microparticle In Response To TNF-{alpha}: Increase Of The Extracellular Thrombogenicity By Microparticle Diffusion Through Endothelium. (2007) (0)
Early Contractile Failure (2005) (0)
ASSOCIATION OF PARVOVIRUS B19 INFECTION WITH CARDIAC AMYLOIDOSIS AND MYOCARDIAL DISEASES POSITIVE FOR AMYLOID FIBRILS AT ELECTRON MICROSCOPY (2010) (0)
Clonal T-cell composition detected by family specific polymerase chain reaction of the T-cell receptor beta chain is exclusively present in dilated cardiomyopathy (2003) (0)
1014-94 Activated Endothelial and Interstitial Cells in Chronic Myocarditis – Expression of Endothelial Adhesion Molecules (1995) (0)
726-6 Diastolic Left Ventricular Function Improves in Patients with Healed Myocarditis Compared to Patients with Ongoing Myocarditis (1995) (0)
Aβ accumulation in brains of NEP-deficient mice. (2013) (0)
161 Anti‐inflammatory properties of atorvastatin exert cardioprotective effects in experimental diabetic cardiopathy (2003) (0)
Abstract 13081: The Toll-Like Receptor 4 Ligands S100a8 and S100a9 are Crucial Factors in Viral Cardiomyopathy (2012) (0)
High-resolution respirometry in human endomyocardial biopsies shows reduced ventricular oxidative capacity related to heart failure (2019) (0)
P4767Impaired myocardial mitochondrial function in type 2 diabetes mellitus heart transplant recipients (2018) (0)
P683Intramyocardial inflammation correlates with poor prognosis in patients with cardiac AL amyloidosis (2018) (0)
Abstract 20099: Adiponectin Inhibits Maladaptive Cardiac Remodeling in Cardiac Disease by Increasing Matrix Metalloproteinase-9 Activity (2014) (0)
ADIPONECTIN PROMOTES CARDIAC REMODELING IN INFLAMMATORY HEART DISEASE BY INDUCTION OF MATRIX METALLOPROTEINASE-9 ACTIVITY (2013) (0)
Abstract 4647: Long-Term Results after Repeated Cryoballoon Ablation of Paroxysmal or Persistent Atrial Fibrillation without On-Top-Therapie (2008) (0)
ADIPONECTIN PROMOTES COXSACKIEVIRUS B3 MYOCARDITIS BY SUPPRESSING THE ACUTE ANTIVIRAL IMMUNE RESPONSE (2013) (0)
[Nitrendipine in patients with coronary disease and hypertension. Acute and long-term effects on hemodynamics and myocardial ischemia]. (1988) (0)
[Pathophysiology and pathobiochemistry of heart failure: the myocardium]. (1991) (0)
Treatment of Inflammatory Cardiomyopathy with Corticosteroids (1997) (0)
Response to Letter Regarding Article, “Biglycan Is Required for Adaptive Remodeling After Myocardial Infarction” (2008) (0)
660 Deficiency of Toll-like receptor 4 leads to cardioprotection against doxorubicin-induced cardiomyopathy (2007) (0)
Optimization of oral anticoagulation: solved and unsolved problems with mechanical heart valve prostheses (1998) (0)
[New concepts in the diagnosis of inflammatory myocardial disease]. (1997) (0)
[Viral myocarditis--new aspects of pathomechanisms, diagnosis and therapy]. (1988) (0)
Contents, Vol. 120, 1945 (1945) (0)
MICRO RNA 181B REGULATES THE DIFFERENTIAL EXPRESSION OF TF ISOFORMS BY BINDING TO TOPOISOMERASE I AND THEREBY LINKS VASCULAR INFLAMMATION TO THROMBOGENICITY (2014) (0)
Abstract 10940: Human Cardiac Biopsy-derived Cells Reduce Angiotensin II-induced Cardiac Remodeling (2012) (0)
Betablocker in der Postinfarktsituation (2002) (0)
377 Cardiac fibrosis correlates with cardiac diastolic stiffness in patients with isolated diastolic heart failure (2006) (0)
192 Interferon beta improves endothelial damage and normalises the number of circulating endothelial progenitor cells in parvovirus B19 positive inflammatory cardiomyopathy (2008) (0)
P5141Biopsy-based diagnosis in a large cohort of 2822 consecutive patients with unexplained heart failure (2017) (0)
ANALYSIS OF PROGNOSTIC VALUE OF PERFORIN IN ENDOMYOCARDIAL BIOPSIES OF PATIENTS WITH DILATED INFLAMMATORY CARDIOMYOPATHY (2013) (0)
2425Evaluation of myocardial gene expression profiling for superior diagnosis of idiopathic giant cell myocarditis in a large cohort of patients with acute cardiac decompensation (2019) (0)
Abstract 4012: Characterization of Adiponectin as an Anti-inflammatory Protein in Patients With Chronic Inflammatory Cardiomyopathy (2009) (0)
The expression of Protease-Activated Receptor (PAR) 2 reduces the IFNbeta expression in the heart (2013) (0)
CCN1: a novel inflammation-regulated biphasic immune cell migration modulator (2012) (0)
244 Cardiac parvovirus type B19 infection is associated with isolated diastolic dysfunction (2004) (0)
VASCULOTROPIC PARVOVIRUS INFECTION IMPAIRS OUTCOME IN INFLAMMATORY CARDIOMYOPATHY (2014) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Heinz‐peter Schultheiss?

Heinz‐peter Schultheiss is affiliated with the following schools:

University of Pennsylvania

Heinz‐peter Schultheiss's Academic­Influence.com Rankings

Why Is Heinz‐peter Schultheiss Influential?

Heinz‐peter Schultheiss's Published Works

Published Works

What Schools Are Affiliated With Heinz‐peter Schultheiss?

Heinz‐peter Schultheiss's AcademicInfluence.com Rankings